HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Infectious Disease
Meta-analysis
Probiotics and postbiotics demonstrate anti-Candida activity by inhibiting growth, biofilm formation, and virulence genes
Probiotics and postbiotics show potential against Candida yeast infections
This systematic review evaluates the anti-Candida activity of probiotics and postbiotics. The authors found that these interventions consist…
New evidence suggests that specific probiotics and their byproducts may help block the growth and spread of Candida yeast infections.
Frontiers
Sep 24, 2026
Dermatology
Sys. Review
Microbiota-directed therapies for atopic dermatitis currently lack consistent human clinical evidence
Microbiome therapies for eczema still lack strong evidence
This narrative review examines microbiota-directed therapies including probiotics, postbiotics, and microbial metabolites for atopic dermati…
A new review finds that microbiome-based treatments for atopic dermatitis are promising but backed by limited human data.
Frontiers
Jul 16, 2026
Gastroenterology
Meta-analysis
Systematic review finds gut microbiota drugs reduce liver enzymes in MASLD patients compared to placebo
New drugs targeting gut bacteria may finally treat fatty liver disease
This systematic review and network meta-analysis evaluated gut microbiota-regulating drugs, including probiotics, prebiotics, synbiotics, an…
New medicines that change gut bacteria lower liver enzymes in fatty liver patients, offering hope for those struggling with diet and exercis…
Apr 27, 2026